# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Richard Newitter reiterates OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target ...
JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 pri...
Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $42 price target.
The Enabling Technologies division will leverage the company's core mission of addressing unmet pediatric needs in orthoped...
Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $42 price target.
Truist Securities analyst Richard Newitter reiterates OrthoPediatrics (NASDAQ:KIDS) with a Hold and lowers the price target ...
OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.2...